Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

Similar articles for PubMed (Select 23533867)

1.

Obstetrical Management of an Extremely Overweight Pregnant Woman (184 kg bw) with Special Attention on Thromboprophylaxis.

Horváth B, Skrapits J, Bódis J.

Case Rep Obstet Gynecol. 2013;2013:689549. doi: 10.1155/2013/689549. Epub 2013 Mar 4.

2.

Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J; American College of Chest Physicians.

Chest. 2008 Jun;133(6 Suppl):844S-886S. doi: 10.1378/chest.08-0761.

PMID:
18574280
3.

Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.

Wu O, Robertson L, Twaddle S, Lowe GD, Clark P, Greaves M, Walker ID, Langhorne P, Brenkel I, Regan L, Greer I.

Health Technol Assess. 2006 Apr;10(11):1-110. Review.

4.
5.

Economic evaluation of enoxaparin for anticoagulation in early cardioversion of persisting nonvalvular atrial fibrillation: a statutory health insurance perspective from Germany.

Schädlich PK, Schmidt-Lucke C, Huppertz E, Lehmacher W, Nixdorff U, Stellbrink C, Brecht JG.

Am J Cardiovasc Drugs. 2007;7(3):199-217.

PMID:
17610347
6.

Obstetrical complications associated with abnormal maternal serum markers analytes.

Gagnon A, Wilson RD, Audibert F, Allen VM, Blight C, Brock JA, Désilets VA, Johnson JA, Langlois S, Summers A, Wyatt P; Society of Obstetricians and Gynaecologists of Canada Genetics Committee.

J Obstet Gynaecol Can. 2008 Oct;30(10):918-49. Review. English, French.

PMID:
19038077
7.

Management of venous thromboembolic disease. The impact of low-molecular-weight heparin.

Tapson VF, Hull RD.

Clin Chest Med. 1995 Jun;16(2):281-94. Review.

PMID:
7656540
8.

Management of pregnant women with mechanical heart valve prosthesis: thromboprophylaxis with low molecular weight heparin.

Abildgaard U, Sandset PM, Hammerstrøm J, Gjestvang FT, Tveit A.

Thromb Res. 2009 Jul;124(3):262-7. doi: 10.1016/j.thromres.2008.12.005. Epub 2009 Jan 21.

PMID:
19162303
9.

Dosing and monitoring of low-molecular-weight heparin in high-risk pregnancy: single-center experience.

Shapiro NL, Kominiarek MA, Nutescu EA, Chevalier AB, Hibbard JU.

Pharmacotherapy. 2011 Jul;31(7):678-85. doi: 10.1592/phco.31.7.678.

10.

[Thromboprophylaxis during pregnancy and the puerperium: highlights from current guidelines].

Rath W.

Z Geburtshilfe Neonatol. 2010 Dec;214(6):217-28. doi: 10.1055/s-0030-1269861. Epub 2011 Jan 4. Review. German.

PMID:
21207321
11.

[Low-molecular-weight heparin in the prevention of thromboembolism in pregnant thrombophilic patients].

Boda Z, László P, Rejtö L, Tornai I, Pfliegler G, Rák K.

Orv Hetil. 1996 Jan 28;137(4):183-5. Hungarian.

PMID:
8721833
12.
13.

Modulation of systemic hemostatic parameters by enoxaparin during gestation in women with thrombophilia and pregnancy loss.

Sarig G, Blumenfeld Z, Leiba R, Lanir N, Brenner B.

Thromb Haemost. 2005 Nov;94(5):980-5.

PMID:
16363240
14.
17.

Thrombin generation post elective caesarean section: effect of low molecular weight heparin.

Ismail SK, Norris L, Muttukrishna S, Higgins JR.

Thromb Res. 2012 Nov;130(5):799-803. doi: 10.1016/j.thromres.2012.01.008. Epub 2012 Feb 24.

PMID:
22365560
18.
19.

[Anesthesiologic aspects of pregnancy and delivery in a patient following a modified Fontan procedure ].

Braun U, Weyland A, Bartmus D, Ruschewski W, Rath W.

Anaesthesist. 1996 Jun;45(6):545-9. German.

PMID:
8767569
20.

Management of thromboembolic disease in pregnancy.

Tan LK, de Swiet M.

Ann Acad Med Singapore. 2002 May;31(3):311-9. Review.

PMID:
12061291
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk